Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body. Albumin is the major carrier molecule in the human body for […]
Daxor Corporation, (NYSE MKT: DXR), a medical instrumentation and biotechnology company, announced that Dr. Wayne Miller, a cardiologist from the Mayo Clinic, presented research at the annual meeting of the Heart Failure Society which documented and quantified blood volume derangements in congestive heart failure patients. The study demonstrated that the majority of congestive heart failure […]
Daxor Corporation, a medical instrumentation and biotechnology company, announced today the appointment of Lisa Quartley as its first SVP, Marketing and Commercial Development. Ms. Quartley will be leading a newly focused and reinvigorated commercialization effort for the company’s unique diagnostic technology with the goal of making direct blood volume measurement a standard of care. A […]
The BVA-100 is the first FDA Approved machine to accurately measure blood volume in as little as 30 minutes. Review our product literature to learn more.